David Jenkins

4PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 13, 2025
Atp1a2 and Kcnj9 Are Candidate Genes Underlying Sensitivity to Oxycodone-Induced Locomotor Activation and Withdrawal-Induced Anxiety-Like Behaviors in C57BL/6 Substrains.

Lisa R Goldberg, Britahny M Baskin, Jacob A Beierle

|Mar 08, 2024
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.

Azadeh C Bashi, Elizabeth A Coker, Krishna C Bulusu

|Jun 26, 2023
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment.

Mark Roschewski, Manish R Patel, Patrick M Reagan

|Nov 03, 2017
Combating subclonal evolution of resistant cancer phenotypes.

Samuel W Brady, Jasmine A McQuerry, Yi Qiao

Pageof 1

Frequent Collaborators

1 joint publications

Samuel W Brady

1 joint publications

Stephen R Piccolo

1 joint publications

Joe W Gray

1 joint publications

Andrea H Bild